
    
      In this parallel group clinical pharmacology laboratory experiment, we will assess
      pharmacodynamic interactions (with a focus on cardiovascular effects) of a 15 mg intravenous
      methamphetamine dose and single oral doses of reserpine (0.5 and 1.0 mg) or placebo.
    
  